Sustained release compositions for treating periodontal disease
November 16, 2010. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent References Re33093 2976251 3867190 Equine anthelmintic Hollow-fiber devices for and a method of the treament and diagnosis of oral diseases Topical anti-inflammatory composition Method and preparation for administration to the mucosa of the oral or nasal cavity Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition Treatment of oral diseases InventorAssigneeApplicationNo. 439064 filed on 11/17/1989US Classes:424/422, Implant or insert424/434, Mucosal (e.g., nasal, etc.)424/435, Mouth424/449Transdermal or percutaneousExaminersPrimary: Page, Thurman K.Assistant: Benston, W. Attorney, Agent or FirmInternational ClassA61F 013/00AbstractThis invention relates to compositions and methods for treating diseases of the oral cavity in humans and lower animals using a glycerol monooleate gel for releasing drugs in the oral cavity. | |
